Literature DB >> 9596644

Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia.

S Faderl1, H M Kantarjian, M Talpaz, Z Estrov.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9596644

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  50 in total

1.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

2.  The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells.

Authors:  Wei-Gang Tong; Zeev Estrov; Yongtao Wang; Susan O'Brien; Stefan Faderl; David M Harris; Quin Van Pham; Inbal Hazan-Halevy; Zhiming Liu; Patricia Koch; Hagop Kantarjian; Michael J Keating; Alessandra Ferrajoli
Journal:  Invest New Drugs       Date:  2010-06-09       Impact factor: 3.850

Review 3.  New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia.

Authors:  Deborah A Thomas; Susan O'Brien; Jorge Cortes; Hagop Kantarjian
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

4.  RT-PCR and real-time PCR analysis of E2A-PBX1, TEL-AML1, mBCR-ABL and MLL-AF4 fusion gene transcripts in de novo B-lineage acute lymphoblastic leukaemia patients in south India.

Authors:  Natarajan Sudhakar; Kamalalayam Raghavan Rajalekshmy; Thangarajan Rajkumar; Karunakaran Nirmala Nancy
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

5.  Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.

Authors:  Valentina Minieri; Marco De Dominici; Patrizia Porazzi; Samanta A Mariani; Orietta Spinelli; Alessandro Rambaldi; Luke F Peterson; Pierluigi Porcu; Marja T Nevalainen; Bruno Calabretta
Journal:  Cancer Res       Date:  2018-08-28       Impact factor: 12.701

6.  Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).

Authors:  Susan J Zunino; David H Storms; Jonathan M Ducore
Journal:  Cancer Lett       Date:  2010-04-09       Impact factor: 8.679

7.  Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.

Authors:  Partow Kebriaei; Rima Saliba; Gabriela Rondon; Alexandre Chiattone; Rajyalakshmi Luthra; Paolo Anderlini; Borje Andersson; Elizabeth Shpall; Uday Popat; Roy Jones; Laura Worth; Farhad Ravandi; Deborah Thomas; Susan O'Brien; Hagop Kantarjian; Marcos de Lima; Sergio Giralt; Richard Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-23       Impact factor: 5.742

8.  Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia.

Authors:  Pavan Reddy; Ramesh Shankar; Teena Koshy; Venkatraman Radhakrishnan; Prasanth Ganesan; P K Jayachandran; Manikandan Dhanushkodi; Nikita Mehra; S Krupashankar; P Manasa; R P Nagare; R Swaminathan; Krishnarathinam Kannan; T G Sagar; T S Ganesan
Journal:  Indian J Hematol Blood Transfus       Date:  2019-04-17       Impact factor: 0.900

9.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

10.  Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine.

Authors:  Alphy Rose-James; R Shiji; P Kusumakumary; Manjusha Nair; Suraj K George; T T Sreelekha
Journal:  Med Oncol       Date:  2016-07-23       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.